Medicare’s Clinical Trials Billing National Coverage Determination is not as simple as it looks. All too often individuals make erroneous determinations about what can be billed based on their first reading of this NCD -- which can lead not only to potential fines, but to lost revenue as well. And watch out -- the OIG and the Department of Justice have realized that the NCD is difficult to implement correctly, and they have begun to focus enforcement resources on this issue.
To get a better grip on CMS’ Clinical Trials Billing Policy, join expert speaker Michael C. Roach, Esq., during this 1-hour encore teleconference. He’ll translate the legal jargon into plain English and help you determine what is billable to Medicare and what is not. Finally, he’ll give you tips on implementing processes to ensure correct billing.
Who should attend: Compliance officers, CFOs, and whoever reviews and negotiates clinical trial agreements for hospitals conducting clinical trial research.
In this jam-packed session you’ll learn:
Your registration includes:
Michael Roach, Esq., has been practicing law as a health care attorney for 18 years. Previously, he was a health care administrator and also conducted health services research. His firm handled the first settlement in the country with the OIG and the Department of Justice focused solely on clinical trials billing issues -- and helped their clients avoid a CIA. Roach graduated cum laude from the University of Richmond School...
More Events By The Speaker